At a glance
ClinicalIndex Comparison RecordN/ACompleted· 50 enrolled
Drug / intervention
tDCS +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Evaluation of the Efficacy of Transcranial Direct Current Stimulation (tDCS) on Neurodegeneration and Neuromotor Recovery on Post-stroke Patients. a Pilot Study
In Brief
A clinical study evaluating tDCS and Conventional rehabilitative treatment for Stroke. Completed, enrolled 50 participants across 1 site.
Detailed Summary
The aim of the study is to evaluate whether a non-invasive brain stimulation technique (Transcranial Direct Current Stimulation) can influence the secondary neurodegeneration observed after a stroke (assessed based on serum concentration of neurofilaments) and can improve the functional outcome.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStroke
CountriesItaly
Collaborators--
Timeline
N/ACompletedFinished
202420252026
Enrollment StartMar 2023
First PostedApr 2023
Primary CompletionFeb 2025
TodayJul 2026
First PostedApr 20, 2023
Enrollment StartMar 2, 2023
Primary CompletionFeb 1, 2025
TodayJul 2, 2026
Enrollment to primary: 1.9 yearsPosted 3.2 years ago
Interventions
tDCSdevice
Use of Transcranial direct current stimulation for 20 minutes per day, 5 days a week, at 2mA
Conventional rehabilitative treatmentother
Physiotherapy treatment consisting in two treatments per day of 40 minutes each